News_克睿基因生物科技有限公司

En Ch

Home

About Us

Introduction

History

Team

Scientific Advisory Board

Science

Technology Platform

Pipeline

Collaborations

News

News

Join Us

Culture

Careers opportunities

Contact information

Dr. Ren Li Appointed Chief Technology Officer at C...

Dr. Ren Li Appointed Chief Technology Officer at C...

Cure Genetics is delighted to announce that Dr. Li Ren has joined the company recently, taking on the role of Chief Technology Officer in Cell Therapy.

More

Cure Genetics and Frametact Limited Enter collabor...

Cure Genetics and Frametact Limited Enter collabor...

Cure Genetics and Frametact Limited, a biotech company specializing in researching and developing treatments for neurological diseases, jointly announce the signing of a collaborative development and licensing agreement.

More

Dr. Shawn He Named Chief Scientific Officer at Cur...

Dr. Shawn He Named Chief Scientific Officer at Cur...

Cure Genetics is delighted to announce that Dr. Shawn He will officially take up his post as the Chief Scientific Officer (CSO) in cell therapy on August 1, 2023. Shawn will guide the navigation of Cure Genetics' cell therapy development, leading the team to break new ground and accelerate the progress of cell therapy pipelines.

More

Cure Genetics and Frametact Reach a $60 Million Co...

Cure Genetics and Frametact Reach a $60 Million Co...

Cure Genetics and Frametact Limited jointly announce the signing of a collaborative development and licensing agreement. The partnership will leverage Cure Genetics' proprietary VELP^TM platform to develop novel Adeno-Associated Virus (AAV) vectors for the treatment of familial neurological diseases.

More

Robert R. Ruffolo Joins CureGenetics's Scientific ...

Robert R. Ruffolo Joins CureGenetics's Scientific ...

In April 2022, Suzhou, China, Cure Genetics, a biotechnology company focusing on development of cutting-edge gene and cell therapies, announced that Dr. Robert R. Ruffolo has joined its Scientific Advisory Board (SAB). Where he will provide scientific guidance to Cure Genetics technology platform and R&D pipeline, as well as assisting the Company’s global partnership effort.

More